Serum Institute of India

The expert panel in its last meeting in April had sought more data from SII following its application seeking the Emergency Use…

"All vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum…

Africa was the only continent that did not have its own manufacturing capacity for COVID shots during the worst phases of the…

Dr Poonawalla has been felicitated with Dean’s medal for his life-long contribution with this honour, reserved for luminaries…

The firm will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI)…

The MoU will see both the entities work towards promoting research and innovation to increase impact of vaccines, technologies and…

The firm is reducing the price of each dose from Rs 900 to Rs 225 plus Goods and Services Tax (GST) for private hospitals. In…

FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December last year and in…

The firm has written to the Ministry of Health and Family Welfare (MoH&FW) that if these 10 crore free doses of Covishield are…